ImmuCell Corporation logo

ImmuCell Corporation

ICCC | NASDAQ
Chart Builder DCF Calculator
$10.26
-$0.06 (-0.58%)
At close: Oct 30, 2026, 4:00 PM ET
$10.26
$0.00 (0.00%)
After-hours: Oct 30, 2026, 7:30 PM ET

Market Data

Market Cap
$93.18M
Enterprise Value
$96.77M
Beta
0.57
Average Volume
21.64K
Shares Outstanding (Diluted)
9.19M
Shares Change YoY
1.75%
Institutional Ownership
14.71%
Exchange
NASDAQ
ISIN
US4525253062

Price Performance

Price Change 1M
4.7%
Price Change 3M
-8.5%
Price Change 6M
17.5%
Price Change YTD
66.8%
Price Change 1Y
64.4%
Price Change 3Y
103.2%
Price Change 5Y
16.6%
1M CAGR (ann.)
3.1%
1Y CAGR (ann.)
70.2%
5Y CAGR (ann.)
1.9%
All-Time CAGR
6.3%

Valuation

PE Ratio
121.28
Forward PE
N/A
PEG Ratio
-0.31
Forward PEG
-0.31
PS Ratio
3.04
Forward PS
4.90
PB Ratio
2.97
P/FCF Ratio
22.11
P/Adj. FCF Ratio
25.46
P/OCF Ratio
15.78
EV/Sales
3.15
EV/EBIT
84.01
EV/EBITDA
27.37
EV/FCF
22.96
Earnings Yield
0.8%
FCF Yield
4.5%
Adj. FCF Yield
3.9%

Financial Health

Net Cash
$557.32K
Total Debt
$12.45M
Cash & Short-Term Investments
$8.86M
Total Assets
$46.63M
Current Ratio
4.75
Quick Ratio
2.71
Debt / Equity Ratio
0.40
Debt / EBITDA
3.52
Debt / FCF
2.95
OCF / Debt
0.47
Interest Coverage
8.93
Altman Z-Score
4.49
Piotroski F-Score
7

Margins & Profitability

Gross Profit Margin
40.3%
Operating Profit Margin
12.6%
EBITDA Margin
11.5%
Net Profit Margin
2.6%
FCF Margin
13.7%
Adj. FCF Margin
11.9%
SBC / Revenue
1.8%
SBC Impact (per share)
-13.2%

Returns

Return on Assets
1.7%
Return on Equity
2.7%
Return on Invested Capital
8.1%
Return on Capital Employed
9.2%
Return on Tangible Assets
1.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
25.1%
Revenue CAGR 5Y
13.7%
Revenue CAGR 10Y
11.3%
EPS CAGR 3Y
361.0%
EPS CAGR 5Y
53.4%
EPS CAGR 10Y
-11.6%
FCF CAGR 3Y
151.7%
FCF CAGR 5Y
1.2%
FCF CAGR 10Y
-28.0%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 12, 2026
EPS Estimate (next Q)
$0.05
EPS Growth Est (next Q)
-350.0%
Revenue Est (next Q)
$5.4M
Revenue Growth Est (next Q)
-1.9%

Fair Value Estimates

Graham Number
$2.57
Graham Upside
-75.0%
Lynch Fair Value
$2.00
Lynch Upside
-80.5%
Price Target
$0.00
Price Target Upside
N/A

Cash Flow

Operating Cash Flow
$5.89M
Free Cash Flow
$4.21M
Adj. Free Cash Flow
$3.66M
FCF Per Share
$0.46
OCF Per Share
$0.65
OCF/S Ratio
19.2%

Income Statement

Revenue
$30.68M
Gross Profit
$12.37M
Operating Income
$3.87M
EBITDA
$3.54M
Net Income
$787.37K
EPS (Diluted)
$0.08
Revenue / Employee
$420.21K
Profit / Employee
$10.79K
Employees
73

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.